Geneva Advisors’s Adtran ADTN Stock Holding History

Geneva Advisors’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-27,398	Closed	-$569K	–	749
2017 Q1	$569K	Buy	+27,398	New	+$595K	0.01%	477

Other funds holding ADTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Geneva Advisors's ADTN Position: Q2 2017 in Review

Geneva Advisors sold out of Adtran (ADTN) in Q2 2017, closing a stake of 27,398 shares — an estimated $569K sold.

Geneva Advisors first reported a position in ADTN in Q1 2017 and held it in 1 quarter. The position peaked at $569K in Q1 2017. 155 funds tracked by Wall St. Rank hold ADTN as of Q2 2017.

Geneva Advisors reported no remaining Adtran position as of Q2 2017 after selling out during the quarter.
Geneva Advisors sold 27,398 Adtran shares in Q2 2017, an estimated $569K.
Geneva Advisors first reported a position in Adtran in Q1 2017 and held it in 1 quarter.
Geneva Advisors's Adtran position peaked at $569K in Q1 2017.
155 funds tracked by Wall St. Rank held Adtran as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.